Tanja Trarbach
- Oncology top 1%
- Pulmonary and Respiratory Medicine top 2%
- Molecular Biology top 10%
- Surgery top 5%
- Hepatology top 2%
- Co-authors
- Dirk LaurentU. VanhoeferFlorian LordickMarkus MoehlerN. SchleucherHauke LangStephan KanzlerGunnar Folprecht
- Topics
- Colorectal Cancer Treatments and Studies (53 papers)Gastric Cancer Management and Outcomes (30 papers)Cancer Treatment and Pharmacology (28 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Tanja Trarbach
91 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 88
- Oncology 1.7k
- Pulmonary and Respiratory Medicine 1.2k
- Molecular Biology 775
- Surgery 609
- Hepatology 423
Countries citing papers authored by Tanja Trarbach
This map shows the geographic impact of Tanja Trarbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tanja Trarbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tanja Trarbach more than expected).
Fields of papers citing papers by Tanja Trarbach
This network shows the impact of papers produced by Tanja Trarbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tanja Trarbach. The network helps show where Tanja Trarbach may publish in the future.
Co-authorship network of co-authors of Tanja Trarbach
This figure shows the co-authorship network connecting the top 25 collaborators of Tanja Trarbach. A scholar is included among the top collaborators of Tanja Trarbach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tanja Trarbach. Tanja Trarbach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 22 | |
| 3 | 18 | |
| 4 | 0 | |
| 5 | 1 | |
| 6 | 176 | |
| 7 | 73 | |
| 8 | 7 | |
| 9 | 34 | |
| 10 | 86 | |
| 11 | 54 | |
| 12 | 5 | |
| 13 | Cetuximab with irinotecan/NA-FA/5-FU as first-line treatment in advanced gastric cancer: Preliminary results of a non-randomised multi-centre AIO phase II study | 8 |
| 14 | 4 | |
| 15 | 2 | |
| 16 | 40 | |
| 17 | 53 | |
| 18 | A meta-analysis of two randomized, double-blind, placebo-controlled, phase III studies in patients (PTS) with metastatic colorectal cancer (MCRC) receiving FOLFOX4 and PTK/ZK to determine clinical benefit on progression-free survival (PFS) in high LDH PTS | 2 |
| 19 | 31 | |
| 20 | 6 |
About Tanja Trarbach
Tanja Trarbach is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Gastroenterology, having authored 93 papers that have together received 2.6k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (53 papers), Gastric Cancer Management and Outcomes (30 papers) and Cancer Treatment and Pharmacology (28 papers). The work is most often cited by research in Oncology (1.7k citations), Hepatology (423 citations) and Pulmonary and Respiratory Medicine (1.2k citations). Tanja Trarbach has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Dirk Laurent, U. Vanhoefer, Florian Lordick, Markus Moehler, N. Schleucher, Hauke Lang, Stephan Kanzler, Gunnar Folprecht, C.-H. Köhne and Andreas Paul. Their work appears in journals such as Journal of Clinical Oncology, Oncogene and Radiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.